This site is optimised for modern browsers. For the best experience, please use Google Chrome, Mozilla Firefox, or Microsoft Edge.


We offer the life sciences industry a range of services and free support.

We can work with you at any stage of your clinical development pipeline, from providing expertise to aid early stage development, to supporting the design, set-up and delivery of your study protocol in the UK’s National Health Service (NHS) and social care system.

Run a commercial study in the NHS

From finding sites to performance monitoring, we provide a range of support to help the life sciences industry run studies in the NHS.

Collaborate with us

We offer a range of opportunities for industry to partner with our experts; from Translational Research Collaborations, to jointly funding researcher career development.

Access our expertise

Discover how we can help you identify, partner and work with the UK’s leading academics and clinical experts and access NHS research intelligence.

Our response to COVID-19

At the beginning of the pandemic, we streamlined the COVID-19 research set-up process in the UK by establishing a single, collective UK system-wide approach involving NIHR, Public Health England, UK Research & Innovation (UKRI), the Health Research Authority (HRA), Medicines and Healthcare products Regulatory Agency (MHRA) and others.

Due to the drop in COVID-19 case numbers and significant progress with the vaccine roll-out, we are no longer accepting applications for studies to be designated as Urgent Public Health (UPH). However existing UPH studies will continue to be prioritised over the coming weeks, and new COVID-19 portfolio studies will be supported in line with local priorities and capacity. Find out more about NIHR support for COVID-19 research

You can read examples of how our support has helped, such as:

You may also find the following resources useful:

Restarting paused research

We’re working on restarting all non-COVID-19 research which was paused due to the pandemic. Our priority now is to ensure that research across the NIHR portfolio can quickly regain momentum.

The NIHR has developed a ‘Framework for restart’ which is a guidance document to support local decision-making. For further information:

  • if you have questions about the pausing or restart of a clinical study:
  • if you are from a company wanting to be connected to the NIHR's expert researchers:

Other key information about what NIHR can offer to industry includes:

  • Apply for funding
    There are a number of NIHR funding programmes which industry can apply for in order to support their health and care research
  • Access NIHR facilities and services
    Support for the life sciences industry and other partners to access data, samples and analytical services

Or, find out more about:

Latest news about the Life Sciences Industry

Latest Case Studies about the Life Sciences Industry


About Us

We are the nation's largest funder of health and care research and provide the people, facilities and technology that enables research to thrive. Working in partnership with the NHS, universities, local government, other research funders, patients and the public, we deliver and enable world-class research that transforms people's lives, promotes economic growth and advances science.

We are primarily funded by the Department of Health and Social Care, but also receive UK Aid funding to support research for people in low- and middle-income countries.

Our Mission

NIHR's mission is to improve the health and wealth of the nation through research. We deliver against this mission through five strategic workstreams.

Our Governance

The NIHR's work is directed by leaders at Department of Health and Social Care working in partnership with the directors of our six coordinating centres.

Our Contribution to Research

The NIHR is a central part of the UK research landscape, collaborating in national activities to improve research and supporting NHS research performance.